Form 4: Zenas BioPharma Director Xiao Ting Acquires 10,000 Shares at $7.76 Each

Director Xiao Ting of Zenas BioPharma, Inc. purchased 10,000 shares of common stock at a weighted average price of $7.76 on February 7, 2025.

Summary

• On February 7, 2025, Xiao Ting, a director of Zenas BioPharma, Inc. (ZBIO), acquired 10,000 shares of common stock.
• The shares were purchased at a weighted average price of $7.76 per share, with individual transactions ranging from $7.64 to $7.78.
• Following the transaction, Xiao Ting directly owns 47,000 shares of ZBIO.
• The purchase was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports a transaction. It's neither particularly positive nor negative from an investment perspective without additional context.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their trading activities. This purchase is not necessarily indicative of a broader trend but reflects the individual investment decisions of the director.

Stakeholder Impact

• The purchase could have a minor positive impact on shareholder sentiment.

Key Dates